Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

s100a4 anticorps

Cet anticorps anti-s100a4 Monoclonal Souris (Clone CPTC-S100A4-3) (ABIN6940543) détecte spécifiquement s100a4 dans WB, IF et FACS. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN6940543
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour s100a4 anticorps (ABIN6940543)

Antigène

Voir toutes s100a4 (S100A4) Anticorps
s100a4 (S100A4) (S100 Calcium Binding Protein A4 (S100A4))

Reactivité

  • 176
  • 100
  • 43
  • 16
  • 5
Humain

Hôte

  • 116
  • 70
  • 3
  • 1
  • 1
Souris

Clonalité

  • 115
  • 76
Monoclonal

Conjugué

  • 76
  • 21
  • 11
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp s100a4 est non-conjugé

Application

  • 139
  • 116
  • 79
  • 77
  • 39
  • 30
  • 24
  • 19
  • 15
  • 13
  • 13
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

CPTC-S100A4-3
  • Fonction

    S100A4 / Metastasin / Calvasculin (Marker of Tumor Metastasis) Antibody

    Specificité

    S100A4 belongs to the S100 super-family of proteins containing 2 EF-hand calcium-binding domains. S100A4 has been implicated in the progression and prognosis of several forms of human cancer, e.g. breast, colorectal, gastric, pancreatic and bladder cancer, SCLC and oesophageal squamous cell carcinoma, among others. Poor prognosis associated with high S100A4 expression is accompanied by clear signs of disease progression, e.g. high histological and clinical grades and involvement of lymph nodes.Also indicative of poor prognosis is high S100A4 expression coupled with reduced E-cadherin expression in pancreatic, oral squamous cell carcinoma and in melanoma. S100A4 expression is inversely related with expression of metastasis suppressor nm23 and with prognosis of breast cancer. S100A4 is overexpressed in highly metastatic cancers, which makes it useful as a marker of tumor progression.

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant human S100A4 full length protein

    Isotype

    IgG2c, kappa
  • Indications d'application

    Positive Control: T98G, HeLa, A549 or A375 cells. Placenta, small intestine.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    s100a4 (S100A4) (S100 Calcium Binding Protein A4 (S100A4))

    Autre désignation

    S100A4

    Sujet

    S100 calcium-binding protein A4, Calvasculin, CAPL, Fibroblast specific protein 1 (FSP1), Leukemia multidrug resistance associated protein, Malignant transformation suppression 1 (MTS1), Metastasin, Placental calcium-binding protein

    A549 or A375 cells. Placenta, HeLa, small intestine., T98G

    Poids moléculaire

    12kDa

    ID gène

    6275, 654444

    UniProt

    P26447

    Pathways

    S100 Proteins
Vous êtes ici:
Chat with us!